ArticleslgStudy

science

Leniolisib

Leniolisib is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Leniolisib rather than just read about it. In short: Leniolisib, sold under the brand name Joenja, is an anti-cancer medication used for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS). It is a kinase inhibitor that is taken by mouth.

Leniolisib — main illustration
Leniolisib — illustration

Key takeaways

  • Leniolisib belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Leniolisib to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Leniolisib from memory before moving on to harder problems.

Reference excerpt

Leniolisib, sold under the brand name Joenja, is an anti-cancer medication used for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS). It is a kinase inhibitor that is taken by mouth. The most common side effects include headache, sinusitis, and atopic dermatitis. Leniolisib was approved for medical use in the United States in March 2023, in the United Kingdom in September 2024, and in the European Union in May 2026. It is the first approved medication for the treatment of activated PI3K delta syndrome. The US Food and Drug Administration considers it to be a first-in-class medication. In 2025 NICE approved it for use in the British NHS.

Medical uses Leniolisib is indicated for the treatment of activated phosphoinositide 3-kinase delta syndrome (activated PI3K delta syndrome) in people twelve years of age and older. Activated PI3K delta syndrome is caused by mutations in either of two genes, PIK3CD or PIK3R1, that regulate the maturation of white blood cells, especially B cells and T cells. This leads to a decrease in immune cells, which makes it difficult for people with activated PI3K delta syndrome to fight off bacterial and viral infections.

Mechanism of action Leniolisib is a selective phosphoinositide 3-kinase inhibitor (PI3Kδ inhibitor), which means it blocks a form of the protein called phosphoinositide 3-kinase delta (PI3Kδ) that is overactive in activated PI3K delta syndrome. By inhibiting PI3Kδ, leniolisib helps normalize immune function as measured by a significant increase in number of immune response generating B cells and reduction in size of lymph nodes.

Adverse effects The most common encountered adverse effects were headache, sinusitis, and atopic dermatitis.

History Leniolisib was developed by Novartis and subsequently licensed to Pharming Group, a Dutch biotechnology company, in 2019. The US Food and Drug Administration (FDA) evaluated the efficacy of leniolisib in the placebo-controlled portion of Study 2201 (NCT02435173), a twelve‑week blinded, randomized, placebo-controlled study of 31 participants twelve years of age and older with confirmed APDS-associated genetic PI3Kδ mutation, with a documented variant in either PIK3CD or PIK3R1. The FDA granted the application for leniolisib orphan drug, priority review, and rare pediatric disease designations.

Society and culture

Legal status Leniolisib was approved for medical use in the United States in March 2023. in the United Kingdom in September 2024, and in the European Union in May 2026.

Names Leniolisib is the international nonproprietary name. Leniolisib is sold under the brand name Joenja.

References

This article incorporates text from this source, which is in the public domain: Bing Chat output modified to create the initial revision of this article. 25 March 2023. – via Microsoft

External links Clinical trial number NCT02435173 for "Study of Efficacy of CDZ173 in Patients With APDS/PASLI" at ClinicalTrials.gov

Illustrations

Leniolisib illustration

Worked examples

Example 1 — a first encounter with Leniolisib

Start with the simplest possible case. Write down what Leniolisib claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Leniolisib before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Leniolisib ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Leniolisib

In research
Leniolisib appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Leniolisib in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Leniolisib is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antineoplastic drugs, Drugs developed by Novartis, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life
Look for Leniolisib outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Leniolisib in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Leniolisib means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Leniolisib out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Leniolisib in simple terms?

Leniolisib, sold under the brand name Joenja, is an anti-cancer medication used for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS). It is a kinase inhibitor that is taken by mouth.

Why does Leniolisib matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Leniolisib?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Leniolisib.

Tags

  • Antineoplastic drugs
  • Drugs developed by Novartis
  • Orphan drugs
  • Phosphoinositide 3-kinase inhibitors

Keep exploring